0

Diabetes Collection
 161-180 of 780 Articles
Therapeutics |  May/Jun 2002
Intensive insulin therapy reduced mortality and morbidity in critically ill patients
Daniel L. Hurley, MD; M. Molly McMahon, MD
Ann Intern Med. 2002;136(3):81. doi:10.7326/ACPJC-2002-136-3-081
Therapeutics |  May/Jun 2002
Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):82. doi:10.7326/ACPJC-2002-136-3-082
Therapeutics |  May/Jun 2002
Irbesartan reduced progression of nephropathy caused by type 2 diabetes independent of the effect on blood pressure
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):83. doi:10.7326/ACPJC-2002-136-3-083
Therapeutics |  May/Jun 2002
Losartan was renoprotective in diabetic nephropathy independent of its effect on blood pressure
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):84. doi:10.7326/ACPJC-2002-136-3-084
Articles |  16 April 2002 FREE
A Diabetes Report Card for the United States: Quality of Care in the 1990s
Jinan B. Saaddine, MD; Michael M. Engelgau, MD; Gloria L. Beckles, MD; et al.
Ann Intern Med. 2002;136(8):565-574. doi:10.7326/0003-4819-136-8-200204160-00005
Articles |  16 April 2002
Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test?
Michael P. Stern, MD; Ken Williams, MS; Steven M. Haffner, MD, MPH
Ann Intern Med. 2002;136(8):575-581. doi:10.7326/0003-4819-136-8-200204160-00006
Articles |  2 April 2002
Administration of Neutral Protamine Hagedorn Insulin at Bedtime versus with Dinner in Type 1 Diabetes Mellitus To Avoid Nocturnal Hypoglycemia and Improve Control: A Randomized, Controlled Trial
Carmine G. Fanelli, MD, PhD; Simone Pampanelli, MD; Francesca Porcellati, MD, PhD; et al.
Ann Intern Med. 2002;136(7):504-514. doi:10.7326/0003-4819-136-7-200204020-00007
Editorials |  2 April 2002
Avoiding Nocturnal Hypoglycemia: Consideration of an Extra Injection at Bedtime
Andrew W. Norris, MD, PhD; Lori M.B. Laffel, MD, MPH
Ann Intern Med. 2002;136(7):547-549. doi:10.7326/0003-4819-136-7-200204020-00013
Articles |  5 February 2002
Dietary Patterns and Risk for Type 2 Diabetes Mellitus in U.S. Men
Rob M. van Dam, MSc; Eric B. Rimm, ScD; Walter C. Willett, MD; et al.
Ann Intern Med. 2002;136(3):201-209. doi:10.7326/0003-4819-136-3-200202050-00008
Articles |  15 January 2002
Profiling Care Provided by Different Groups of Physicians: Effects of Patient Case-Mix (Bias) and Physician-Level Clustering on Quality Assessment Results
Sheldon Greenfield, MD; Sherrie H. Kaplan, PhD, MPH; Richard Kahn, PhD; et al.
Ann Intern Med. 2002;136(2):111-121. doi:10.7326/0003-4819-136-2-200201150-00008
Ideas and Opinions |  18 December 2001
Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Guidelines Based on Current Evidence
Norman M. Kaplan, MD
Ann Intern Med. 2001;135(12):1079-1083. doi:10.7326/0003-4819-135-12-200112180-00012
Ideas and Opinions |  6 November 2001
Clinical Inertia
Lawrence S. Phillips, MD; William T. Branch, MD; Curtiss B. Cook, MD; et al.
Ann Intern Med. 2001;135(9):825-834. doi:10.7326/0003-4819-135-9-200111060-00012
Quality Indicators for Assessing Care of Vulnerable Elders |  16 October 2001 FREE
ACOVE Quality Indicators
Ann Intern Med. 2001;135(8_Part_2):653-667. doi:10.7326/0003-4819-135-8_Part_2-200110161-00004
Editorials |  3 July 2001
Helping Patients Take Responsibility for Their Own Health
Andrew Herxheimer, MB, FRCP
Ann Intern Med. 2001;135(1):51-52. doi:10.7326/0003-4819-135-1-200107030-00013
Editorials |  19 June 2001
Editor's World
Frank Davidoff, MD, Editor
Ann Intern Med. 2001;134(12):1144-1146. doi:10.7326/0003-4819-134-12-200106190-00016
Articles |  1 May 2001
Maternally Inherited Diabetes and Deafness: A Multicenter Study
Pierre-Jean Guillausseau, MD; Pascale Massin, MD; Danièle Dubois-LaForgue, MD; et al.
Ann Intern Med. 2001;134(9_Part_1):721-728. doi:10.7326/0003-4819-134-9_Part_1-200105010-00008
Articles |  1 May 2001
Avoidance of Hypoglycemia Restores Hypoglycemia Awareness by Increasing β-Adrenergic Sensitivity in Type 1 Diabetes
Andreas Fritsche, MD; Norbert Stefan, MD; Hans Häring, MD; et al.
Ann Intern Med. 2001;134(9_Part_1):729-736. doi:10.7326/0003-4819-134-9_Part_1-200105010-00009
Articles |  1 May 2001
The Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly Controlled with Sulfonylurea and Metformin: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Jean-François Yale, MD; Thomas R. Valiquett, MS; Mahmoud N. Ghazzi, MD, PhD; et al.
Ann Intern Med. 2001;134(9_Part_1):737-745. doi:10.7326/0003-4819-134-9_Part_1-200105010-00010
Editorials |  1 May 2001
Mitochondrial DNA Mutations and Diabetes: Another Step toward Individualized Medicine
Nathan Fischel-Ghodsian, MD
Ann Intern Med. 2001;134(9_Part_1):777-779. doi:10.7326/0003-4819-134-9_Part_1-200105010-00014
Articles |  6 March 2001
Should All Patients with Type 1 Diabetes Mellitus and Microalbuminuria Receive Angiotensin-Converting Enzyme Inhibitors?: A Meta-Analysis of Individual Patient Data
The ACE Inhibitors in Diabetic Nephropathy Trialist Group*
Ann Intern Med. 2001;134(5):370-379. doi:10.7326/0003-4819-134-5-200103060-00009
Advertisement

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)